Charts Actuate Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 11:09:04 2026-10-28 am EDT			5-day change	1st Jan Change
0.3690 ^USD	-7.63%		-33.16%	-93.86%

Oct. 07	Top Premarket Decliners	MT
Sep. 09	Actuate Therapeutics Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with Ras Inhibitors Zoldonrasib and Daraxonrasib	CI

NasdaqUSD

Markets		Quality
Nasdaq	ACTU	Delayed
CBOE	ACTU	Real-time

ProRealTime Chart